Entamoeba histolytica is a particularly tenacious parasite. The single-celled amoeba generally arrives in the colon after contaminated water and food is ingested—most often in places with poor ...

The single-celled parasite Entamoeba histolytica infects 50 million people each year, killing nearly 70,000. Usually, this wily, shape-shifting amoeba causes nothing worse than diarrhea. But sometimes ...

The single-celled parasite Entamoeba histolytica infects 50 million people each year, killing nearly 70,000. Usually, this wily, shape-shifting amoeba causes nothing worse than diarrhea.

That's right, folks, the little parasites — called Entamoeba histolytica — don't even have the courtesy to kill your cells before they take a bite. They don't even digest the parts they eat.

Epidemiological studies also underline the importance of host factors in E. histolytica infection; in particular, the re-infection rates in a study population have been found to be 2.7-times ...

The pathogenesis of a potentially fatal amoeba, Entamoeba histolytica (E. histolytica), has been discovered, showing that the organism uses a process coined as trogocytosis, to nibble sections of a ...

The single-celled parasite Entamoeba histolytica infects approximately 50 million people each year, causing nearly 70,000 deaths. In most cases, this shape-shifting amoeba causes only mild ...

One type of parasite, Entamoeba histolytica, has developed a very intriguing way to do this. It rips pieces off human cells and steals the proteins to wear them as a disguise.

Next-generation drugs against the sometimes fatal disease amebiasis could result from a RIKEN researcher’s new strategy targeting a source of iron that an infectious protozoan parasite needs to ...

Entamoeba histolytica is a protozoan parasite that causes amoebiasis. Recent studies have revealed opportunities to produce an effective vaccine against the Entamoeba histolytica infection.

Entamoeba histolytica has the unusual ability to kill human cells and then wear them as a disguise to escape the immune defenses. The research, the teams said, could pave the way for new ...